Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5656197 | 0.86 | APOBEC3A (0.55) | NPC1RAB9AKMT2AMEN1ALDH1A1 | |
| SCHEMBL3769883 | 0.83 | MEN1 (0.56) | NPC1RAB9AKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL29797867 | 0.75 | NPC1 (0.56) | NPC1RAB9AKDM4ELMNAL3MBTL1 | |
| SCHEMBL5187236 | 0.74 | LMNA (0.44) | NPC1RAB9AKMT2AMEN1TSHR | |
| SCHEMBL6773752 | 0.73 | RAB9A (0.46) | NPC1RAB9AKMT2AMEN1TSHR | |
| SCHEMBL8359492 | 0.73 | KMT2A (0.76) | KMT2AMEN1TSHRTDP1KDM4E | |
| SCHEMBL1003508 | 0.73 | HDAC1 (0.71) | KMT2AMEN1TSHRTDP1KDM4E | |
| SCHEMBL28713425 | 0.72 | NPC1 (0.61) | NPC1RAB9ATDP1ALDH1A1MAPT | |
| SCHEMBL13272883 | 0.71 | NPC1 (0.73) | NPC1RAB9AKMT2A | |
| SCHEMBL27827575 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7842812-B2 | Substituted 5-aminomethy1-1H-pyrrole-2-carboxylic acid amides | GRUENENTHAL GMBH (DE) | 2010-11-30 | — | — | US | disclosed |
| US-20070135494-A1 | Substituted 5-aminomethyl-1H-pyrrole-2-carboxylic acid amides | GRUENENTHAL GMBH (DE) | 2007-06-14 | — | — | US | disclosed |
| US-7229991-B2 | Substituted 5-aminomethyl-1H-pyrrole-2-carboxamides | GRUENENTHAL GMBH (DE) | 2007-06-12 | — | — | US | disclosed |
| US-20050288342-A1 | Substituted 5-aminomethyl-1H-pyrrole-2-carboxamides | GRUENENTHAL GMBH (DE) | 2005-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070135494-A1 | Substituted 5-aminomethyl-1H-pyrrole-2-carboxylic acid amides | AVPR2, GPR119, AVPR1B | NPC1 2758/4885RAB9A 1104/4885KMT2A 1381/4885 |
| US-20050288342-A1 | Substituted 5-aminomethyl-1H-pyrrole-2-carboxamides | QPCT, PGA5, ALDH18A1 | NPC1 3335/4885RAB9A 688/4885KMT2A 1319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.